400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Membrane Transporter/Ion Channel / CFTR / Tezacaftor
CAS No.: 1152311-62-0
Synonyms: VX-661
VX-661 is a F508del CFTR corrector and is believed to help CFTR protein reach the cell surface.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03447249 | Cystic Fibrosis | Phase 3 | Active, not recruiting | April 16, 2019 | - |
NCT03460990 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT03447262 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | April 24, 2021 | - |
实验方案
技术信息
CAS号 | 1152311-62-0 | 储存条件 |
|
|||||||||||||
分子式 | C26H27F3N2O6 | 运输 | 蓝冰 | |||||||||||||
分子量 | 520.50 | 别名 | VX-661 | |||||||||||||
溶解度 |
|
动物实验配方 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03447249 | Cystic Fibrosis | Phase 3 | Active, not recruiting | April 16, 2019 | - |
NCT03460990 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT03447262 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | April 24, 2021 | - |
NCT03227471 | Cystic Fibrosis | Phase 1 Phase 2 | Completed | - | - |
NCT03525574 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | June 2021 | - |
NCT03224351 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT03525548 | Cystic Fibrosis | Phase 3 | Active, not recruiting | March 2019 | - |
NCT03029455 | Cystic Fibrosis | Phase 1 | Completed | - | United Kingdom ... more >> Birmingham, United Kingdom Cambridge, United Kingdom Exeter, United Kingdom Glasgow, United Kingdom Leeds, United Kingdom Liverpool, United Kingdom London, United Kingdom Manchester, United Kingdom Newcastle upon Tyne, United Kingdom Southampton, United Kingdom Collapse << |
NCT03537651 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | December 2020 | - |
NCT03633526 | Cystic Fibrosis | Phase 3 | Recruiting | January 2020 | United States, Colorado ... more >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 United States, Illinois Ann & Robert Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 United States, Missouri The Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 United States, North Carolina Clinical Research of Charlotte Recruiting Charlotte, North Carolina, United States, 28277 United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT03691779 | Cystic Fibrosis | Phase 3 | Recruiting | January 2020 | United States, California ... more >> Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 United States, New York Northwell Health- Long Island Jewish Medical Center Recruiting New Hyde Park, New York, United States, 11040 United States, Ohio Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Collapse << |
NCT03768089 | Cystic Fibrosis | Phase 1 Phase 2 | Recruiting | March 2019 | Netherlands ... more >> Academic Medical Center Recruiting Amsterdam, Netherlands PRA Health Sciences Onderzoekscentrum UMCG Recruiting Groningen, Netherlands United Kingdom The Medicines Evaluation Unit Recruiting Manchester, United Kingdom Collapse << |
NCT03525444 | Cystic Fibrosis | Phase 3 | Active, not recruiting | August 2019 | - |
NCT02951182 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT03486236 | Cystic Fibrosis | Phase 1 | Completed | - | United Kingdom ... more >> The Medicines Evaluation Unit Manchester, United Kingdom Collapse << |
NCT02951195 | Cystic Fibrosis | Phase 2 | Completed | - | United States, Alabama ... more >> Birmingham, Alabama, United States United States, California La Jolla, California, United States Los Angeles, California, United States United States, Florida Orlando, Florida, United States United States, Illinois Chicago, Illinois, United States Peoria, Illinois, United States United States, Missouri Saint Louis, Missouri, United States United States, North Carolina Chapel Hill, North Carolina, United States United States, Ohio Akron, Ohio, United States Cleveland, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, South Carolina Charleston, South Carolina, United States United States, Texas Fort Worth, Texas, United States Houston, Texas, United States United States, Wisconsin Madison, Wisconsin, United States Collapse << |
NCT02508207 | Cystic Fibrosis | Phase 2 | Completed | - | United States, Alabama ... more >> Birmingham, Alabama, United States United States, Indiana Indianapolis, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, North Carolina Chapel Hill, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States Toledo, Ohio, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States Collapse << |
NCT02508207 | - | - | Completed | - | - |
NCT02412111 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01531673 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT02070744 | - | - | Completed | - | - |
NCT02516410 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02070744 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT02347657 | - | - | Completed | - | - |
NCT02730208 | Cystic Fibrosis | Phase 2 | Completed | - | Australia ... more >> Chermside, Australia Melbourne, Australia Nedlands, Australia New Lambton Heights, Australia Parkville SIC, Australia Randwick, Australia South Brisbane, Australia Subiaco, Australia Westmead, Australia Collapse << |
NCT01531673 | - | - | Completed | - | - |
NCT02015507 | Cystic Fibrosis | Phase 1 | Completed | - | - |
NCT02347657 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02516410 | - | - | Completed | - | - |
NCT02565914 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | September 2019 | - |
NCT02953314 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02392234 | - | - | Completed | - | - |
NCT02392234 | Cystic Fibrosis | Phase 3 | Completed | - | - |
靶点 | Description | IC50 |
---|
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网